SHBG and metabolic dysfunction-associated steatotic liver disease: Recently, increasing evidence from epidemiological studies has showed that lower SHBG levels are predictive of a higher risk for NAFLD and these studies highlighted SHBG as an important hepatokine in NAFLD progression (19, 20, 26).